Liu Peng, Chen Yao, Xiao Jing, Zhu Wenhui, Yan Xiaoming, Chen Ming
Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing, China.
Department of Medicine, Renal Division, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Front Pharmacol. 2023 Jan 12;13:1093397. doi: 10.3389/fphar.2022.1093397. eCollection 2022.
Metabolic syndrome (MS) is a complex group of metabolic disorders syndrome with hypertension, hyperuricemia and disorders of glucose or lipid metabolism. As an important organ involved in metabolism, the kidney is inevitably attacked by various metabolic disorders, leading to abnormalities in kidney structure and function. Recently, an increasing number of studies have shown that mitochondrial dysfunction is actively involved in the development of metabolic-associated kidney diseases. Mitochondrial dysfunction can be used as a potential therapeutic strategy for the treatment of metabolic-associated kidney diseases. Many natural products have been widely used to improve the treatment of metabolic-associated kidney diseases by inhibiting mitochondrial dysfunction. In this paper, by searching several authoritative databases such as PubMed, Web of Science, Wiley Online Library, and Springer Link. We summarize the Natural Products Protect Against Metabolic-Associated Kidney Diseases by Regulating Mitochondrial Dysfunction. In this review, we sought to provide an overview of the mechanisms by which mitochondrial dysfunction impaired metabolic-associated kidney diseases, with particular attention to the role of mitochondrial dysfunction in diabetic nephropathy, gouty nephropathy, hypertensive kidney disease, and obesity-related nephropathy, and then the protective role of natural products in the kidney through inhibition of mitochondrial disorders, thus providing a systematic understanding of the targets of mitochondrial dysfunction in metabolic-associated kidney diseases, and finally a review of promising therapeutic targets and herbal candidates for metabolic-associated kidney diseases through inhibition of mitochondrial dysfunction.
代谢综合征(MS)是一组复杂的代谢紊乱综合征,伴有高血压、高尿酸血症以及糖或脂代谢紊乱。肾脏作为参与代谢的重要器官,不可避免地受到各种代谢紊乱的侵袭,导致肾脏结构和功能异常。近年来,越来越多的研究表明线粒体功能障碍积极参与了代谢相关性肾脏疾病的发生发展。线粒体功能障碍可作为治疗代谢相关性肾脏疾病的一种潜在治疗策略。许多天然产物已被广泛用于通过抑制线粒体功能障碍来改善代谢相关性肾脏疾病的治疗。在本文中,通过检索PubMed、Web of Science、Wiley Online Library和Springer Link等多个权威数据库,我们总结了天然产物通过调节线粒体功能障碍预防代谢相关性肾脏疾病的研究。在这篇综述中,我们试图概述线粒体功能障碍损害代谢相关性肾脏疾病的机制,特别关注线粒体功能障碍在糖尿病肾病、痛风性肾病、高血压肾病和肥胖相关性肾病中的作用,以及天然产物通过抑制线粒体紊乱对肾脏的保护作用,从而系统了解代谢相关性肾脏疾病中线粒体功能障碍的靶点,最后综述通过抑制线粒体功能障碍治疗代谢相关性肾脏疾病的潜在治疗靶点和草药候选物。